Antibodies against connective tissue growth factor (CTGF) and their uses

CO20260012198A2Pending Publication Date: 2026-08-31BOEHRINGER INGELHEIM INT GMBH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CO20260012198
Authority / Receiving Office
CO · CO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-02-27
Filing Date
2026-08-24
Publication Date
2026-08-31
Patent Text Reader

Abstract

This disclosure generally refers to anti-CTGF (connective tissue growth factor) antibodies or antigen-binding fragments thereof. The example anti-CTGF antibodies disclosed herein address the need for treatments of conditions modulated by CTGF signaling. In some respects, anti-CTGF antibodies or antigen-binding fragments thereof are for therapeutic and / or diagnostic use, for example, in a subject who needs them, such as a human being.
Need to check novelty before this filing date? Find Prior Art